- Home
- TOPS vs PMN Comparison
TOPS vs PMN Comparison
Compare TOPS & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TOPS | PMN |
|---|---|---|
| Founded | 2000 | 2004 |
| Country | Greece | Canada |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.1M | 23.5M |
| IPO Year | 2004 | N/A |
Fundamental Metrics
Financial Performance| Metric | TOPS | PMN |
|---|---|---|
| Price | $5.36 | $8.36 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $72.67 |
| AVG Volume (30 Days) | ★ 19.9K | 15.2K |
| Earning Date | 10-07-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.30 | N/A |
| Revenue | ★ $87,872,000.00 | N/A |
| Revenue This Year | $9.90 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.26 | ★ N/A |
| Revenue Growth | ★ 4.77 | N/A |
| 52 Week Low | $4.45 | $6.27 |
| 52 Week High | $11.47 | $39.75 |
Technical Indicators
Market Signals| Indicator | TOPS | PMN |
|---|---|---|
| Relative Strength Index (RSI) | 48.04 | 66.09 |
| Support Level | $5.15 | $8.08 |
| Resistance Level | $5.51 | $8.51 |
| Average True Range (ATR) | 0.27 | 0.44 |
| MACD | 0.04 | -0.11 |
| Stochastic Oscillator | 60.87 | 89.16 |
Price Performance
Historical ComparisonAbout TOPS TOP Ships Inc.
TOP Ships Inc owns tanker vessels throughout the world. The Company is an international owner and operator of modern, fuel-efficient eco tanker vessels focusing on the transportation of crude oil, petroleum products (clean and dirty), and bulk liquid chemicals. It generates revenue from the Time Charter agreements.
About PMN ProMIS Neurosciences Inc. (ON)
ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.